City of Hope researchers have developed a modular 'plug-and-play' CAR T-cell platform that enables post-infusion ...
Researchers at the CHOP have developed a new strategy to improve the effectiveness of GPC2-directed CAR T-cell therapy in neuroblastoma by reprogramming the tumor immune microenvironment. Researchers ...
Expects to begin screening patients for the Phase 1 clinical trial by the end of the first quarter; initial data presentation expected in 2023 ROR1-targeted CAR T-cell therapy designed to overcome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results